News

Rolling Out14h
These two numbers control your entire HIV treatment future
Discover how understanding your viral load and CD4 count puts you in control of HIV treatment and transforms confusing ...
The Pharma Letter19h
High costs and limited access threaten progress in HIV treatment despite new drug advances
Despite major strides in antiretroviral therapy (ART), the human immunodeficiency virus (HIV) market still faces serious ...
Healthline8d
FDA Approves 'Breakthrough' Twice-Yearly Injection to Prevent HIV
The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...
FDA approves new twice-yearly HIV shot. What to know
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
Greek Reporter11d
FDA Approves New HIV Prevention Shot Given Twice a Year
The US Food and Drug Administration (FDA) has approved a new shot to prevent HIV, offering a long-acting alternative to daily ...
Everyday Health on MSN11d
FDA Approves a ‘Game-Changing’ Twice-a-Year HIV Prevention Shot
The new HIV PrEP option could drastically reduce the number of new cases by offering a new alternative to daily pills or ...
Infectious Disease Advisor8d
Long-Acting CAB Plus RPV Effective for HIV Suppression, Preferred Over Daily Oral ART
LA CAB plus RPV effectively maintained virologic suppression among patients with infection in real-world clinical practice.
Frontiers1d
Evolution of antiretroviral therapy: Transitioning from three-drug to two-drug HIV regimens
The field of HIV treatment has witnessed a significant transformation since the mid-1990s with the introduction of combination antiretroviral therapy ...
ConsumerAffairs11d
FDA approves twice-yearly injection for HIV prevention
FDA Approves Yeztugo as First Twice-Yearly Injectable HIV Prevention Option in the U.S. Clinical Trials Show Near-Perfect ...
FDA approves twice-a-year injection for HIV prevention
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...